Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 218-664-7 | CAS number: 2212-81-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
- Endpoint:
- basic toxicokinetics in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- 2019
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- other: OECD319b
- Deviations:
- yes
- Remarks:
- See below
- Principles of method if other than guideline:
- The aim of the OECD 319B is to determine the in vitro intrinsic clearance (CL in vitro int) of a test chemical using the substrate depletion approach. This can be applied to increase modelled predictions of bioaccumulation in fish. In short the clearance rate can be inputted into toxicokinetic models for fish bioaccumulation or extrapolated to a whole body biotransformation rate. See test guideline. The aim of this assay is to ultimately reduce animal testing in groups of similar substances, by more extensive use of such alternative tests. In addition the assay can be implemented in a simpler fashion to determine if a product is transformed and can be useful to aid degradation product identification. In this memo the
implementation of the assay for Trout and Rat liver is summarized and one test chemical was tested using the assay in order to establish if biotransformation occurred. No intrinsic clearance rate was calculated at this stage. - GLP compliance:
- no
- Radiolabelling:
- no
- Conclusions:
- No metabolic activity was observed for the test chemical.
- Executive summary:
The test chemical was used during the implementation of the OECD 319B assay. Performance of the assay was assessed using testosterone as a standard to demonstrate activity using both trout and rat liver S9 fractions. Multiple tests were conducted to establish an optimal concentration for use in subsequent tests as a positive control. After which, both rat and trout liver fractions gave an acceptable levels of testosterone metabolism and showed a sufficient level of reproducibility. Should definitive tests
take place an additional standard for phase II enzyme activity and day to day test variation still requires validation.
The test substance di(tert-butylperoxyisopropyl)benzene was tested with a rat liver S9 fraction at 50 and 200 μ/moles. No metabolic activity was observed for the test chemical. The meta isomer only was quantified. The reference material at 50 μ/moles performed normally demonstrating sufficient phase 1 activity in the cell line used.
Reference
Description of key information
Short description of key information on bioaccumulation potential result:
Limited substance specific data on metabolism and kinetics are available.
The test substance di(tert-butylperoxyisopropyl)benzene was tested with a rat liver S9 fraction at 50 and 200 μ/moles. No metabolic activity was observed for the test chemical. The meta isomer only was quantified. The reference material at 50 μ/moles performed normally demonstrating sufficient phase 1 activity in the cell line used.
Based on physical-chemical characteristics, no or only limited absorption by the dermal and inhalation routes is expected.
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
- Absorption rate - oral (%):
- 100
- Absorption rate - dermal (%):
- 10
- Absorption rate - inhalation (%):
- 100
Additional information
No data on toxicokinetics, metabolism and distribution are available for the source and target substance. This is not a testing requirement according to EU REACH. The assessment of the toxicokinetics is based on the available toxicological data and its physicochemical properties as suggested by the REACH Guidance Chapter R.7c.
The molecular weight is 338.48 g/mol for the meta and para isomers. The substances are poorly soluble in water (0.04 and 0.02 mg/L, respectively) and have a very low vapor pressure (0.00012 Pa at 20 °C). The logKow of both meta and para isomers is >6.5 a logBCF of 3.96 was calculated. Based on its physico–chemical properties, the substances are not likely to penetrate skin to a large extent as both are solids, nearly insoluble in water and with a Log Kow not in favor of dermal uptake. The low absorption rate is further supported by the acute dermal toxicity study results for the source substance. Moreover, both substances are not a skin irritant; therefore, no increase of skin absorption is expected by damaged skin. Based on the low solubility in water and its high lipophilic properties, the substances could be absorbed in a large extent following oral exposure. The high absorption rate is further supported by the repeated oral toxicity study results where adverse effects were observed. Based on the very low vapor pressure and on the high granulometry of the powder fraction, inhalation exposure is unlikely. However, if exposed, it is likely the substance will also be absorbed.
Therefore, for both substance in their risk assessments, according to the REACH Guidance, default values of 100, 10 and 100% will be used for oral, dermal and inhalation absorptions, respectively.
Two studies are available that investigated the breakdown of the source substance, contain both the meta- and the para-isomer.The first study (Erhardt et al, 2009) concluded that rapid metabolism was seen with a metabolic half- life of 67 minutes or 1.13 hours. However, as noted by ECHA in 2017 in a decision for 25155-25-3,“Some critical remarks can be made to the in vitro metabolism study itself (--,2009). In the study, the concentration of tert-butanol, a potential metabolite ofthe registered substance, is followed as well as the parent substance.The disappearance of the parent compound from the biologically active 59 incubation issignificant, but at the same time highly variable. The coefficient of variation for the threereplicates are on average about 50%, but for the 5th time point of the biologically activetreatment even exceeds 100%. Thus, the rate of metabolism has wide confidenceintervals, but this is not addressed in the registration dossier. Further, on average, theamount disappeared from the heat-treated deactivated test is similar to the biologicallyactive 59 incubation. However, the lowest amounts of parent compound are present atthe intermediate time points (3,4,5) for the deactivated incubation, while they are present at the last time points (4,5,6) for the biologically active S9 incubation. Theamount of the metabolite in the heat-treated deactivated incubation is about ten timeshigher than in the biologically active 59 incubation, which can be explained by the factthat the $9 incubation metabolizes tert-butanol as well. However, in both treatmentsthere is no significant trend of the concentration of tert-butanol in time at all. This is incontradiction with the assumption that tert-butanol is formed as a result of metabolicactivity during the test. Finally, there is no complete mass balance in this kind of testand without the quantification of all metabolites, the dissipation of the parent compoundcan be caused by other processes as well. From other tests, such as the reproductiontest with Daphnia magna, it has become clear that it is extremely difficult to maintainaqueous concentrations of the registered substance in a static exposure system.”
Therefore, an additional study (Kean, 2019) was performed with the source substance to try and reproduce the finding from 2009. This study is a non-GLP adaptation of the OECD 319B assay. Performance of the assay was assessed using testosterone as a standard to demonstrate activity using both trout and rat liver S9 fractions. Multiple tests were conducted to establish an optimal concentration for use in subsequent tests as a positive control. After which, both rat and trout liver fractions gave an acceptable levels of testosterone metabolism and showed a sufficient level of reproducibility. The source substance was tested with a rat liver S9 fraction at 50 and 200 μ/moles, the meta isomer only was quantified. No metabolic activity was observed in this assay. The results from 2009 were therefore not confirmed.
Based on these findings it can be assumed that the toxicity observed is caused by the parent substance and/or its breakdown products. The data presented in appendix II shows that in (eco)toxicological studies the source and target substance have similar toxicological effects and that therefore similartoxicokinetics, metabolism and distribution profile for the parents andbreakdown products are also expected.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.